M L 22 (Lisinopril 2.5 mg)

Pill imprint M L 22 has been identified as Lisinopril 2.5 mg.

Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; alport syndrome; coronary artery disease (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lisinopril

Imprint:

M L 22

Strength:

2.5 mg

Color:

Blue

Size:

6.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Angiotensin converting enzyme inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-2072

Inactive Ingredients:

silicon dioxide
croscarmellose sodium
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
povidone
corn starch
sodium lauryl sulfate
FD&C Blue No. 2

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
51079-0256	UDL Laboratories Inc

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.